Marks & Clerk are partnering with Global IP Strategy to deliver a global discussion on patentability issues in the Biopharma space.
Will Arends, partner at Marks & Clerk will be leading the discussion on Biopharma Patent Ecosphere: Global updates on G2/21, plausibility, sufficiency and enablement. He will be joined by a number of experts who will provide insights on the evolving landscape of biopharma patentability.
Details of the full panel will follow shortly.
Registration is FREE. More information and how to register can be found on the below link.
Time: 9am EST / 3pm CET
60 minute webinar